Carlsmed, Inc. CARL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.51% | -20.86% | -0.96% | -1.02% | -26.01% |
| Total Depreciation and Amortization | -3.08% | 31.31% | 1.02% | 19.51% | 34.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.97% | 34.94% | 80.65% | 3.56% | -1.91% |
| Change in Net Operating Assets | -18.99% | 89.82% | -534.82% | 210.12% | 18.94% |
| Cash from Operations | -17.89% | 43.43% | -144.45% | 37.10% | -20.12% |
| Capital Expenditure | -133.88% | -53.16% | -8.22% | 54.09% | 51.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.25% | -15,282.68% | 99.47% | -13,028.80% | 46.67% |
| Cash from Investing | 90.86% | -9,442.23% | 99.15% | -6,964.14% | 48.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 51.03% | -44.27% | 1,976.19% | -99.98% | 274,800.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 98.19% | -21.18% |
| Cash from Financing | -29.22% | -44.27% | 1,603.45% | -100.03% | 4,138.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.53% | -109.53% | 56.81% | -136.12% | 922.30% |